Table 3.
Ideal features for wireframe prototype.
| Features | Challenges | Possible solutions | |
| Must-have features | |||
|
|
Knowledge on medication use and their side effects | Which medication to choose and when to use it | Chatbot (Figure 2) |
|
|
Knowledge on medication use and their side effects | Generic instruction versus specific instruction | Chatbot (Figure 2) |
|
|
Knowledge on medication use and their side effects | Alternative treatments preferable to steroids | Chatbot (Figure 2) |
|
|
Knowledge on the symptoms and appropriate management | Understanding the disease course and the complications related to ADa | Chatbot (Figure 2) |
|
|
Knowledge on the external triggers leading to ADa flares | Understanding the causes, triggers, and symptoms of AD | Chatbot (Figure 2) |
|
|
Monitoring of skin conditions | Understanding the causes, triggers, and symptoms of AD | Disease diary (Figure 2) |
|
|
Monitoring of skin conditions | Understanding the disease course and the complications related to AD | Journal (Figure 2) |
|
|
Communication channels with health care professionals | Understanding the causes, triggers, and symptoms of AD | Teleconsultation (Figure 2) |
|
|
Communication channels with health care professionals | Understanding the disease course and the complications related to AD | Teleconsultation (Figure 2) |
|
|
Communication channels with health care professionals | Which medication to choose and when to use it | Teleconsultation (Figure 2) |
|
|
Communication channels with health care professionals | Generic instruction versus specific instruction | Teleconsultation (Figure 2) |
|
|
Communication channels with health care professionals | Alternative treatments preferable to steroids | Teleconsultation (Figure 2) |
|
|
Monitoring of external triggers that may lead to AD flares | Understanding the causes, triggers, and symptoms of AD | Disease diary (Figure 2) and disease monitor (Figure 2) |
| Nice-to-have features | |||
|
|
Debunking the myths about AD | Alternative treatments preferable to steroids | Chatbot (Figure 2) |
|
|
Knowledge on the natural history and development of AD | Understanding the causes, triggers, and symptoms of AD | Chatbot (Figure 2) |
|
|
Reminders for topical application and medication taking | Which medication to choose and when to use it | Disease monitor (Figure 2) |
|
|
Peer support from other caregivers or patients | Understanding the causes, triggers, and symptoms of AD | Forum (Figure 2) |
|
|
Peer support from other caregivers or patients | Understanding the disease course and the complications related to AD | Forum (Figure 2) |
|
|
Peer support from other caregivers or patients | Which medication to choose and when to use it | Forum (Figure 2) |
|
|
Peer support from other caregivers or patients | Generic instruction versus specific instruction | Forum (Figure 2) |
|
|
Peer support from other caregivers or patients | Alternative treatments preferable to steroids | Forum (Figure 2) |
|
|
Peer support from other caregivers or patients | Guilt and frustration | Forum (Figure 2) |
|
|
Peer support from other caregivers or patients | Self-esteem | Forum (Figure 2) |
|
|
Peer support from other caregivers or patients | Duty to make their child feel better | Forum (Figure 2) |
|
|
Monitoring of caregivers’ and children’s emotions | Guilt and frustration | Disease diary (Figure 2) |
|
|
Monitoring of caregivers’ and children’s emotions | Self-esteem | Journal (Figure 2) |
|
|
Monitoring of caregivers’ and children’s emotions | Duty to make their child feel better | Journal (Figure 2) |
|
|
Emotional support with interactive app features | Guilt and frustration | Forum (Figure 2) |
|
|
Emotional support with interactive app features | Self-esteem | Teleconsultation (Figure 2) |
|
|
Emotional support with interactive app features | Duty to make their child feel better | Teleconsultation (Figure 2) |
aAD: atopic dermatitis.